Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Status:
Terminated
Trial end date:
2016-10-17
Target enrollment:
Participant gender:
Summary
Evaluated Exjade efficacy and safety in patients with aplastic anemia and
transfusion-dependent iron overload, undergoing treatment programs of immunosuppressive
treatment (Cyclosporine A) , in comparison with a group of patients undergoing treatment
programs of immunosuppressive treatment (Cyclosporine A) without chelation therapy.